Contact this trialFirst, we need to learn more about you.
Corticosteroid
Abrocitinib for Chronic Hand Dermatitis
Recruiting0 awardsPhase 2
Montréal, Quebec
This trial will test a new drug called abrocitinib to see if it is safe and effective for treating chronic hand eczema. Researchers will also look at how well the drug is tolerated by
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.